VIDEN IVS: Financial statements 2019
CVR: 38666649
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
VIDEN IVS (CVR 38666649) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 200. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 200
- Total Assets
- DKK 200
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of June 24, 2019, Andreas Theodor Ifversen is registered as director of VIDEN IVS.
As of June 24, 2019, Bertel Peter Ifversen has stepped down as director of VIDEN IVS.
On June 24, 2019, the company changed its name from VandNatur IVS to VIDEN IVS.
As of June 5, 2019, Bertel Peter Ifversen is registered as director of VIDEN IVS.
As of June 5, 2019, Andreas Theodor Ifversen has stepped down as director of VIDEN IVS.
On June 5, 2019, the company changed its name from VIDEN IVS to VandNatur IVS.
VIDEN IVS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK 0.
About VIDEN IVS
VIDEN IVS was a Danish company of the type Iværksætterselskab based in Snedsted, founded in 2017. The company has been dissolved on 25 February 2022. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named VandNatur IVS. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2020 report amounted to DKK 200.